Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
NobleOak Life Limited (NOL.AX)
Sydney, NSW, AU
NobleOak Life Limited engages in underwriting life insurance products in Australia. It offers life, income protection, total and permanent disability, death, trauma, business expenses, and self-managed super fund insurance plans. The company sells its insurance products through direct-to-market and strategic partner channels. The company was formerly known as United Ancient Order of Druids Friendly Society of NSW and changed its name to NobleOak Life Limited in 2011. NobleOak Life Limited was founded in 1861 and is headquartered in Sydney, Australia.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.40% | +0.81% | -2.34% | -6.72% | -11.97% | -11.35% | -8.09% | -27.75% | -35.90% | -35.90% | -35.90% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 2 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Insurance - Life: +10.6%-67.9% Q4'25: +35.7% (vs Q4'23)
-
EPS growth Insurance - Life: +13.4%-29.6% Q4'25: +36.0% (vs Q4'23)
-
FCF margin FCF growth · Insurance - Life: +31.7%+35.9% ★ Q4'25: +0.7% (vs Q4'23)
-
EBIT margin Insurance - Life: +12.4%+12.4% ★ Q4'25: +3.6% (vs Q4'23)
-
ROIC Insurance - Life: +1.0%+9.9% ★ Q4'25: +67.3% (vs Q4'23)
-
Share dilution Insurance - Life: +0.4%+3.9% Q4'25: +10.0% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Insurance - Life: -1.05×0.30× Q4'25: 0.23× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Jun 2022 actual |
Jun 2023 actual |
Jun 2024 actual |
Jun 2025 actual |
Jun 2026 1 Rev. Ana. 1 EPS Ana. |
Jun 2027 1 Rev. Ana. 1 EPS Ana. |
Jun 2028 1 Rev. Ana. 1 EPS Ana. |
Jun 2029 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|
| Revenue |
75.43M
est: 240.33M (-68.6%)
|
343.40M
est: 330.34M (+4.0%)
|
386.65M
est: 365.51M (+5.8%)
|
123.99M
est: 438.56M (-71.7%)
|
522.98M
522.98M – 522.98M
+19.3% YoY
|
597.33M
597.33M – 597.33M
+14.2% YoY
|
677.26M
675.88M – 678.63M
+13.4% YoY
|
768.52M
768.52M – 768.52M
+13.5% YoY
|
| EBITDA |
4.22M
est: 20.48M (-79.4%)
|
18.67M
est: 28.15M (-33.7%)
|
20.33M
est: 31.15M (-34.7%)
|
15.42M
est: 37.38M (-58.7%)
|
44.57M
44.57M – 44.57M
+19.3% YoY
|
50.91M
50.91M – 50.91M
+14.2% YoY
|
57.72M
57.60M – 57.84M
+13.4% YoY
|
65.50M
65.50M – 65.50M
+13.5% YoY
|
| EBIT |
2.65M
est: 18.03M (-85.3%)
|
17.03M
est: 24.78M (-31.3%)
|
13.54M
est: 27.42M (-50.6%)
|
15.42M
est: 32.90M (-53.1%)
|
39.23M
39.23M – 39.23M
+19.3% YoY
|
44.81M
44.81M – 44.81M
+14.2% YoY
|
50.81M
50.70M – 50.91M
+13.4% YoY
|
57.65M
57.65M – 57.65M
+13.5% YoY
|
| Net Income |
1.69M
est: 7.23M (-76.7%)
|
7.99M
est: 10.76M (-25.7%)
|
9.28M
est: 16.63M (-44.2%)
|
7.12M
est: 17.83M (-60.1%)
|
19.38M
19.08M – 19.69M
+8.7% YoY
|
22.46M
21.28M – 23.64M
+15.9% YoY
|
25.13M
25.13M – 25.13M
+11.9% YoY
|
31.75M
31.75M – 31.75M
+26.4% YoY
|
| SGA |
41.62M
est: 52.03M (-20.0%)
|
50.41M
est: 71.52M (-29.5%)
|
26.44M
est: 79.14M (-66.6%)
|
—
est: 94.95M (-100.0%)
|
113.23M
113.23M – 113.23M
+19.3% YoY
|
129.33M
129.33M – 129.33M
+14.2% YoY
|
146.63M
146.34M – 146.93M
+13.4% YoY
|
166.39M
166.39M – 166.39M
+13.5% YoY
|
| EPS |
0.02
est: 0.08 (-74.7%)
|
0.09
est: 0.12 (-20.5%)
|
0.11
est: 0.19 (-40.8%)
|
0.08
est: 0.19 (-59.0%)
|
0.21
0.21 – 0.21
+8.7% YoY
|
0.24
0.23 – 0.26
+15.9% YoY
|
0.27
0.27 – 0.27
+11.9% YoY
|
0.35
0.35 – 0.35
+26.4% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C+ | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-28 | C+ | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-27 | C+ | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-26 | C+ | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-22 | C+ | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-21 | C+ | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-20 | C+ | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-19 | C+ | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-18 | C+ | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-15 | C+ | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-14 | C+ | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-12 | C+ | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-11 | C+ | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-08 | C+ | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-07 | C+ | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-06 | C+ | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-05 | C+ | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-04 | C+ | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-01 | C+ | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-28 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-24 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-23 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-22 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-21 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-20 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-17 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-16 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 2/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Anthony R. Brown | Chief Executive Officer & Executive Director | 984.2K | male |
| Scott Pearson | Chief Financial Officer | 649.7K | male |
| Christopher Gale | Chief Growth Officer | — | male |
| Amanda Underwood | General Counsel & Company Secretary | — | — |
| Kirsten Booth | Chief Risk Officer | — | female |
| Martin Paino | Appointed Actuary | — | — |
| Moana Kolesi | Head of Sales | — | female |
| Gary Bailison | Chief Operations Officer | — | male |
| Cathy Doyle | Chief People Officer | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for NOL.AX
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
